Poncirin( —— )

Catalog No. M18052 CAS No. 14941-08-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Poncirin
Note

Research use only, not for human use.
Brief Description

Poncirin shows a significant in vitro inhibitory effect on the growth of the human gastric cancer cells, SGC-791, in a dose-dependent manner.
Description

Poncirin shows a significant in vitro inhibitory effect on the growth of the human gastric cancer cells, SGC-791, in a dose-dependent manner. Poncirin prevents adipogenesis, enhances osteoblast differentiation in mesenchymal stem cellsincreased bone mineral density, and improves trabecular microarchitecture likely reflect increases bone formation and decreases bone resorption in GIO mice.
In Vitro

——
In Vivo

Poncirin (intraperitoneal administration; 30 mg/kg) markedly reduces the pain behavior in both acetic acid-induced visceral pain and formalin-induced tonic pain models inComplete Freund’s Adjuvant (CFA)-induced inflammatory pain model.
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

ERK
Recptor

Others
Research Area

——
Indication

——

CAS Number

14941-08-3
Formula Weight

594.56
Molecular Formula

C28H34O14
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (168.19 mM)
SMILES

CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)OC)O)CO)O)O)O)O)O
Chemical Name

——